1
by Singh, Kavita, Argáez, Charlene
Published 2018
Canadian Agency for Drugs and Technologies in Health
... effectiveness and safety of this treatment for moderate to severe plaque psoriasis in adults...

2
by Singh, Kavita, Argáez, Charlene
Published 2018
Canadian Agency for Drugs and Technologies in Health
... effectiveness and safety of this treatment for moderate to severe plaque psoriasis in adults...

3
by Ho, Chuong, Argáez, Charlene
Published 2019
Canadian Agency for Drugs and Technologies in Health
... (first line) use of biologics in the sequencing of pharmacological treatments for patients with moderate...

4
by Ho, Chuong, Argáez, Charlene
Published 2019
Canadian Agency for Drugs and Technologies in Health
... (first line) use of biologics in the sequencing of pharmacological treatments for patients with moderate...

5
by Edge, Rob, Argáez, Charlene
Published 2017
Canadian Agency for Drugs and Technologies in Health
... for low to moderate near-sightedness (myopia). Photorefractive keratectomy (PRK), was developed over 20...

6
by Edge, Rob, Argáez, Charlene
Published 2017
Canadian Agency for Drugs and Technologies in Health
... for low to moderate near-sightedness (myopia). Photorefractive keratectomy (PRK), was developed over 20...